EFX
47
4
AMP
69
3
DUK
55
-2
AAL
50
-4
D
43
-2
CF
48
3
EL
52
-10
ADP
61
-3
CCI
36
2
AN
63
2
ES
45
5
CCL
55
-2
AIG
56
3
DAL
74
-2
AAP
36
-5
DTE
42
2
CI
42
-3
ACN
56
-3
EMN
52
-3
APH
58
2
EFX
47
4
AMP
69
3
DUK
55
-2
AAL
50
-4
D
43
-2
CF
48
3
EL
52
-10
ADP
61
-3
CCI
36
2
AN
63
2
ES
45
5
CCL
55
-2
AIG
56
3
DAL
74
-2
AAP
36
-5
DTE
42
2
CI
42
-3
ACN
56
-3
EMN
52
-3
APH
58
2
Financhill
Back

Jasper Therapeutics, Inc. 10K Form

Sell
16

JSPR
Jasper Therapeutics, Inc.

Last Price:
$1.85
Seasonality Move:
-19.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive JSPR News And Ratings

See the #1 stock for the next 7 days that we like better than JSPR

JSPR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-17M
Price / Cash Flow: 0
Annual Sales: $0.41
Price / Book: 3.99

Profitability

EPS (TTM): -5.90340
Net Income (TTM): $-91M
Gross Margin: $-1.4M
Return on Equity: -204.39%
Return on Assets: -133.52%

Jasper Therapeutics, Inc. Earnings Forecast

Key Jasper Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 3 years.

Jasper Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: JSPR
Website: jaspertherapeutics.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 2.59
Quick Ratio: 2.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

JSPR Technical Analysis vs Fundamental Analysis

Sell
16
Jasper Therapeutics, Inc. (JSPR) is a Sell

Is Jasper Therapeutics, Inc. a Buy or a Sell?